Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

A series of live interactive workshops featuring expert perspectives on managing patients with aggressive B-cell lymphomas. Live simulcasts of 3 workshops will be available as well as a downloadable slideset treatment summary resource guides and an on-demand webcast covering these important topics.

Share

Program Content

Activities

Aggressive B-Cell Lympomas Slides
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2022

Expires: March 07, 2023

Activities

ADCs for B-Cell Lymphoma
Antibody–Drug Conjugates for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

Bispecific Abs in B-Cell Lymphomas
Bispecific Antibodies in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

BTKi for B-Cell Lymphomas
BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

CAR T-cells for B-Cell Lymphomas
CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

IMiDs and ICIs for B-Cell Lymphomas
Immunomodulatory Agents and Immune Checkpoint Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

Ab-Based Tx in B-cell Lymphomas
Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

XPO1 Inhibitors for B-Cell Lymphomas
XPO1 and Nuclear Export Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

Activities

B-Cell Lymphomas: New Adv
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

Expires: November 15, 2023

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Hagler Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Satish Shanbhag, MD

Hematologist/Oncologist
Cancer Specialists of North Florida

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Genmab US Inc and AbbVie

Karyopharm Therapeutics

Novartis Pharmaceuticals Corporation